CaMKK2 as an emerging treatment target for bipolar disorder.
Kaiser J, Nay K, Horne CR, McAloon LM, Fuller OK, Muller AG, Whyte DG, Means AR, Walder K, Berk M, Hannan AJ, Murphy JM, Febbraio MA, Gundlach AL, Scott JW.
Kaiser J, et al. Among authors: walder k.
Mol Psychiatry. 2023 Nov;28(11):4500-4511. doi: 10.1038/s41380-023-02260-3. Epub 2023 Sep 20.
Mol Psychiatry. 2023.
PMID: 37730845
Free PMC article.
Review.